US Dementia Diagnoses Will Double by 2060

American families can expect a doubling of new dementia diagnoses within the next three decades. A projection published in 2024 estimates that annual new cases in the United States will grow from 514,000 in 2020 to one million by 2060. This increase will place additional strain on a healthcare system that experts describe as already under pressure, particularly following recent federal funding adjustments.

The global trend mirrors the domestic shift. A new study in JAMA Neurology estimates that worldwide annual new dementia cases will rise from 11.4 million in 2023 to 24.7 million in 2050. In the US, the drivers are demographic rather than medical. Longer life expectancy means more people are reaching ages where dementia is most common. The growth of the Hispanic population is another factor. That group nearly doubled between 2000 and 2024. The Alzheimer's Association notes that Hispanic people are 1.5 times as likely as white people to develop the condition.

Jordan Weiss, an assistant professor at the Optimal Aging Institute at NYU Langone, explained that demographic shifts are inevitable. He stated that even if risk factors decrease, the sheer number of adults entering high-risk age groups will drive up case counts. This creates a fixed baseline of patients that the system must support regardless of medical breakthroughs.

The workforce designed to care for these patients is thinning. A 2024 report from the American Health Care Association found that almost all nursing facilities struggled to recruit staff. Two-thirds of those facilities cited a lack of qualified candidates as a primary issue. About half reported limiting new admissions due to staffing shortages. The demand for nursing assistants and home health aides is expected to rise by 48% and 42% respectively between 2020 and 2035, according to the Center for American Progress.

Wages for these essential roles remain low. The Bureau of Labor Statistics reported that the median wage for nursing assistants in assisted living and home healthcare was under $19 an hour in May 2025. Home health aides earned a median of $17 an hour. Regina Shih, a professor of epidemiology at Emory University, noted that retention is low because the work is difficult. She added that this labor cannot be replaced by artificial intelligence.

The supply of geriatric doctors has also declined. A JAMA report found that the US had 10,270 geriatricians in 2000 but only 7,413 in 2022. The specialty is among the lowest-paid in medicine. Weiss identified compensation as a key reason for the shortage. This gap leaves fewer specialists available to manage complex long-term care needs.

State governments are attempting to address the staffing gaps. A KFF survey found that almost half of states offered incentive payments in 2025 to recruit or retain Medicaid home care workers. South Carolina created a loan forgiveness program for physicians who complete geriatrics fellowships and practice in the state for at least five years. These efforts are now set against a backdrop of federal cuts. The One Big Beautiful Bill Act, passed in 2025, included nearly $1 trillion in Medicaid cuts over 10 years. KFF reports that Medicaid pays for more than half of US long-term care spending.

Medical options exist but are limited. The FDA has approved two drugs, Kisunla and Leqembi, that can modestly slow cognitive decline in some early Alzheimer's patients. Blood tests can also help diagnose the illness and predict risk. Julie Zissimopoulos, a professor at the University of Southern California, said these advances may improve lives but will be costly for the healthcare system.

With no cure currently available, Weiss urged against simply waiting for one. He highlighted the opportunity to lower dementia risk through better cardiovascular health and physical activity. He added that while breakthroughs matter, the priority must be building a system capable of delivering the care that people already need.